Sin et al. reported that the treatment with Trp2 peptides and CpG-oligodeoxynucleotide induced Ag-specific IFN-γ and CD8+ CTL responses and caused the antitumor activities against large melanoma tumors. Here, CD8A is linked to melanoma.